This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: ADI HES ONNN PANW S

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Analog Devices (ADI - Get Report) was upgraded at Jefferies to buy. $56 price target. Company should continue to return the majority of its cash to shareholders in the coming years, Jefferies said.

Adtran (ADTN) was upgraded at Goldman Sachs to buy from neutral. $28 price target. Company should benefit from a multiyear upgrade cycle, Goldman said.

Advanced Micro (AMD) was upgraded to buy from underperform at Bank of America/Merrill Lynch. $6 price target. Estimates were also increased, as the company is gaining market share with consoles.

Advanced Micro was upgraded at Canaccord Genuity to buy from hold. $5 price target. Ramp in the embedded business should continue to accelerate, Canaccord Genuity said.

On Assignment (ASGN) was downgraded at Deutsche Bank to hold from buy. Valuation call, based on a $29 price target, Deutsche Bank said.

Concur Technologies (CNQR) was initiated with a neutral rating at J.P. Morgan. Valuation call, based on an $80 price target, J.P. Morgan said.

China Cord Blood (CO) was upgraded to buy at TheStreet Ratings.

Community Health (CYH) was initiated with a buy rating at Keybanc. $58 price target. Company has a solid track record and should receive above-average benefits from health care reform, Keybanc said.

Sourcefire (FIRE) was downgraded at UBS to neutral from buy based on valuation. Price target is $62.

Finisar (FNSR) was upgraded at Needham to strong buy from buy. $22 price target. Management meetings suggest that positioning and visibility are improving, Needham said.

Hess (HES - Get Report) was upgraded at J.P. Morgan to overweight from neutral. $84 price target. Asset sale program can help unlock value, J.P. Morgan said.

Health Management (HMA) was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $16 price target, Credit Suisse said.

Jive Software (JIVE) was downgraded at UBS to neutral from buy. Valuation and sluggish demand for enterprise software, said UBS. Price target is $19.

KB Home (KBH) was upgraded at CRT Capital to buy from hold. $23 price target. Earnings are coming in well ahead of expectations, CRT Capital said.

Lamar (LAMR) was upgraded at Citigroup to buy from neutral. The IRS is expected to rule in favor of the REIT transition, said Citigroup. Price target goes to $53.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ADI $58.88 -0.19%
HES $75.43 -1.59%
PANW $143.05 0.70%
ONNN $12.86 6.99%
S $4.77 -3.83%

Markets

DOW 18,214.42 -10.15 -0.06%
S&P 500 2,110.74 -3.12 -0.15%
NASDAQ 4,987.89 +20.7530 0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs